Stocks from the healthcare sector were not popular with investors on Tuesday.
The securities of the laboratory supplier Sartorius ultimately fell by 2.85 percent to 335.30 euros via XETRA at the end of the DAX. They slipped back below the 200-day line, which is receiving great attention on the market as an indicator of the longer-term trend.
Bayer shares fell 2.16 percent to 30.08 euros at the close of trading. At times it even fell to its lowest level since the end of 2005. The US court proceedings surrounding the weed killer glyphosate and concerns about possible additional provisions had a latent impact on the price. A trader also pointed out that the US investment house Wolfe Research had lowered the shares from “Outperform” to “Peer Perform”.
The shares of Merck KGaA lost 1.4 percent to 151.55 euros. As on the previous day, the chemical and pharmaceutical company’s stocks missed the jump back above the 200-day line. The line has represented stubborn resistance for the price since spring of last year.
/bek/jha/
TRADE FOREX CFDS NOW WITH UP TO LEVERAGE 30
Trade Forex CFDs with small spreads. With just €100.00 you can trade with the effect of €3,000 in capital.
82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.